
- Peptide Substrates
- Binding Proteins
- Secondary Antibodies
- Regulatory proteins
- 脂类激酶
- 双加氧酶与蛋白质
- 脂质底物
- E2
- Assay Buffer and Co-factors
- Methyltransferases
- Acetyltransferases
- Transcription Proteins
- COVID-19 ELISA Kits
- Tau Proteins
- Microtubule & Actin Associated Proteins
- Carbohydrate Substrates
- COVID-19 Proteins
- Chemokines
- 标记抗体
- 授予称号
- E3
- 【桥头火锅】品牌介绍→桥头火锅底料_重庆桥头火锅_买购网
- SignalChem|生产厂家|价格信息
- signalchem
- IL4 Gene GeneCards | IL4 Protein | IL4 Antibody
- 代理产品SignalchemSignalchem
- 重组人IL11说明书
- cell signaling 三天审稿完毕,小修! 论文投稿 交流 ...
- ...SignalChem一级代理,SignalChem中国代理,SignalChem公司_环保...
- “不积极”英语是什么?unactive吗?
- “不积极”英语是什么?unactive吗?
- 苏州蚂蚁淘实验试剂有限公司17年8月份销售过的产品1苏州蚂蚁淘...
- SignalChem安徽代理 |产品目录|代理商|蚂蚁淘进口试剂平行进口

Overview:
c-KIT is a proto-oncogene and a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). c-KIT was first identified as the cellular homolog of the feline sarcoma viral oncogene v-kit.c-KIT together with its ligand regulates growth and activation of a variety of hemopoietic and non-hemopoietic cells. Mutations in c-KIT are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous lukemia, and piebaldism. Recently, deregulation of the KIT receptor TK by the prevalent activation loop mutation D816V has served as a focal point in therapeutic strategies aimed curbing neoplastic mast cell growth (2).
Gene Aliases:
PBT, SCFR, CD117
Genbank Number:
NM_000222
References:
1. Berger, S A.: Signaling pathways influencing SLF and c-kit-mediated survival and proliferation. Immunol Res. 2006;35(1-2):1-12.2. Gotlib, J.: KIT mutations in mastocytosis and their potential as therapeutic targets. Immunol Allergy Clin North Am. 2006 Aug;26(3):575-92.